On April 30, 2026, President Trump signed another executive order (“EO”) that may significantly impact how the government buys goods and services. The target: cost-reimbursement contracts, which let ...

This program will provide law schools, faculty, clinical programs, and students with a practical introduction to how AI is ...

Summary: CISA warns of Iranian‑linked cyber activity aimed at disrupting U.S. critical infrastructure. Recent attacks ...

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) is the most significant change to U.S. cosmetic regulation since the Federal Food, Drug, and Cosmetic Act (FD&C Act) was enacted in 1938.

The traditional approach to negotiating representations and warranties (R&W) and allocating risk in mergers and acquisitions ...

Every so often a law that was passed years ago quietly becomes a present-day compliance reality. Section 24220 of the 2021 ...

The Chair of the New Mexico Environmental Improvement Board (NMEIB) signed a Final Order and Statement of Reasons on April 17 ...

Key Takeaways FDA has proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list. The proposal would materially limit 503B bulk compounding of these GLP-1 products. Comments ...

Rescheduling marijuana to Schedule III is a big deal for a lot of reasons we’ve covered extensively here at Budding Trends.

A recent decision by the New York Appellate Division, Third Department, has unsettled the legal foundation of the state’s Section 8 housing voucher program, signaling that New York state and New York ...

Over the last three decades, 40 states have legalized the sale and use of medical marijuana in one form or another. Last week, the federal government followed suit, and the policy change could have ...

Introduction: The 2025 M&A Landscape From Prada’s headline-grabbing purchase of Versace to e.l.f. Beauty’s $1 billion bet on Rhode, 2025 reshaped dealmaking across fashion and beauty, with momentum ...